Maravai LifeSciences Holdings, Inc.
MRVI
$2.06
$0.052.49%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -147.93% | 75.33% | -1,432.62% | -15.96% | -17,926.87% |
| Total Depreciation and Amortization | 8.41% | 11.91% | 7.20% | 23.30% | 26.09% |
| Total Amortization of Deferred Charges | -37.70% | -11.44% | 2.17% | 2.06% | 2.92% |
| Total Other Non-Cash Items | -26.97% | -93.51% | 5,250.84% | 240.08% | -104.66% |
| Change in Net Operating Assets | 151.59% | -520.93% | -32.35% | -87.92% | -115.57% |
| Cash from Operations | -10.90% | -287.91% | -7.27% | -9.17% | -109.95% |
| Capital Expenditure | 7.59% | 65.18% | 45.72% | 61.88% | 28.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -48.35% | -76.44% | -219.87% | 325.09% | -81.94% |
| Cash from Investing | -444.98% | 61.78% | 42.27% | 74.41% | 93.91% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -2.52% | -15,245.74% | -2.43% | -5.75% | -10.66% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -230.22% | -71.51% | -- | -- | -330.33% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -42.18% | -360.31% | 20.10% | 104.19% | 113.58% |
| Cash from Financing | -775.00% | -50,352.98% | 3.32% | 100.53% | 97.08% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -181.41% | -5,408.46% | 973.20% | 123.87% | -243.36% |